Nav: Home

Automated CT biomarkers predict cardiovascular events better than current practice

March 04, 2020

Researchers at the National Institutes of Health and the University of Wisconsin have demonstrated that using artificial intelligence to analyze CT scans can produce more accurate risk assessment for major cardiovascular events than current, standard methods such as the Framingham risk score (FRS) and body-mass index (BMI).

More than 80 million body CT scans are performed every year in the U.S. alone, but valuable prognostic information on body composition is typically overlooked. In this study, for example, abdominal scans done for routine colorectal cancer screening revealed important information about heart-related risks - when AI was used to analyze the images.

The study compared the ability of automated CT-based body composition biomarkers derived from image-processing algorithms to predict major cardiovascular events and overall survival against routinely used clinical parameters. The investigators found that the CT-based measures were more accurate than FRS and BMI in predicting downstream adverse events including death or myocardial infarction, cerebrovascular accident, or congestive heart failure. The results appeared in The Lancet Digital Health.

"We found that automated measures provided more accurate risk assessments than established clinical biomarkers," said Ronald M. Summers, M.D., Ph.D., of the NIH Clinical Center and senior author of the study. "This demonstrates the potential of an approach that uses AI to tap into the biometric data embedded in all such scans performed for a wide range of other indications and derive information that can help people better understand their overall health and risks of serious adverse events."

The study used five AI computer programs on abdominal CT scans to accurately measure liver volume and fatty change, visceral fat volume, skeletal muscle volume, spine bone mineral density, and artery narrowing. Researchers found that not only did the combination of automated CT-based biomarkers compare favorably with the FRS and BMI for predicting cardiovascular events and death before any symptoms were present but in fact, the CT measure of aortic calcification, that is buildup of calcium deposits in the aortic valve, alone significantly outperformed the FRS for major cardiovascular events and overall survival.

The researchers also observed that BMI was a poor predictor of cardiovascular events and overall survival, and all five automated CT-based measures clearly outperformed BMI for adverse event prediction.

"This opportunistic use of additional CT-based biomarkers provides objective value to what doctors are already doing," said Perry J. Pickhardt, M.D., of the University of Wisconsin School of Medicine & Public Health, lead and corresponding author of the study. "This automated process requires no additional time, effort, or radiation exposure to patients, yet these prognostic measures could one day impact patient health through presymptomatic detection of elevated cardiovascular or other health risks."

This research builds on prior efforts designing AI algorithms that Dr. Summers has undertaken in his lab in the NIH Clinical Center's Radiology and Imaging Sciences Department and his previous collaboration with Dr. Pickhardt to develop, train, test, and validate fully automated algorithms for measuring body composition using abdominal CT. The researchers plan to test the approach in other studies, including more racially diverse populations.
-end-
This study was supported by the NIH Intramural Research Program, and it used the high-performance computing capabilities of the NIH Biowulf cluster.

About the NIH Clinical Center: The NIH Clinical Center is the clinical research hospital for the National Institutes of Health. Through clinical research, clinician-investigators translate laboratory discoveries into better treatments, therapies and interventions to improve the nation's health. More information: https://clinicalcenter.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Reference

1. Pickhardt P, Summers R, et al. Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population: a retrospective cohort study. The Lancet Digital Health. March 2, 2020. DOI: 10.1016/S2589-7500(20)30025-X

NIH/National Cancer Institute

Related Artificial Intelligence Articles:

Researchers rebuild the bridge between neuroscience and artificial intelligence
In an article in the journal Scientific Reports, researchers reveal that they have successfully rebuilt the bridge between experimental neuroscience and advanced artificial intelligence learning algorithms.
Artificial intelligence can help some businesses but may not work for others
The temptation for businesses to use artificial intelligence and other technology to improve performance, drive down labor costs, and better the bottom line is understandable.
Artificial intelligence could help predict future diabetes cases
A type of artificial intelligence called machine learning can help predict which patients will develop diabetes, according to an ENDO 2020 abstract that will be published in a special supplemental section of the Journal of the Endocrine Society.
Artificial intelligence for very young brains
Montreal's CHU Sainte-Justine children's hospital and the ÉTS engineering school pool their expertise to develop an innovative new technology for the segmentation of neonatal brain images.
Putting artificial intelligence to work in the lab
An Australian-German collaboration has demonstrated fully-autonomous SPM operation, applying artificial intelligence and deep learning to remove the need for constant human supervision.
Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.
Artificial intelligence and family medicine: Better together
Researcher at the University of Houston are encouraging family medicine physicians to actively engage in the development and evolution of artificial intelligence to open new horizons that make AI more effective, equitable and pervasive.
Artificial Intelligence to improve the precision of mammograms
The Artificial Intelligence techniques, used in combination with evaluations by expert radiologists, improve the precision in the detection of cancer through mammograms.
Using artificial intelligence to assess ulcerative colitis
Researchers from Tokyo Medical and Dental University (TMDU) have developed an artificial intelligence system with a deep neural network that can effectively evaluate endoscopic data from patients with ulcerative colitis, which is a type of inflammatory bowel disease, without the need for biopsy collection.
Robot uses artificial intelligence and imaging to draw blood
Rutgers engineers have created a tabletop device that combines a robot, artificial intelligence and near-infrared and ultrasound imaging to draw blood or insert catheters to deliver fluids and drugs.
More Artificial Intelligence News and Artificial Intelligence Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.